AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
MGNX vs MGX Fundamental Comparison
| Metric | MGNX | MGX |
|---|---|---|
| Revenue | $149.5M | $25.2M |
| Net Income | $-74.6M | $-87.9M |
| Net Margin | -49.9% | -348.5% |
| ROE | -134.2% | -55.4% |
| ROA | -29.1% | -39.7% |
| Current Ratio | 5.10x | 7.22x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.18 | $-2.36 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MGNX vs MGX: Frequently Asked Questions
Is MGNX or MGX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. MGNX is rated STRONG SELL (92% confidence) while MGX is rated STRONG SELL (92% confidence). This is not investment advice.
How does MGNX compare to MGX fundamentally?
MACROGENICS INC has ROE of -134.2% vs Metagenomi Therapeutics, Inc.'s -55.4%. Net margins are -49.9% vs -348.5% respectively.
Which stock pays higher dividends, MGNX or MGX?
MGNX has a dividend yield of N/A or no dividend while MGX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MGNX or MGX for long term?
For long-term investing, consider that MGNX has STRONG SELL rating with 92% confidence, while MGX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MGNX vs MGX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MGNX vs MGX, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.